AMGN
42
-4
SIG
44
-3
O
17
-13
SHW
62
-6
XYL
35
-2
ROST
57
-3
OXY
36
-2
CAH
48
-6
AIV
64
4
CSX
57
-4
GRMN
67
-4
FOXA
52
-14
GILD
47
-8
ORLY
60
-5
WEC
53
5
TJX
62
-2
GME
66
-5
IFF
47
-4
CFG
74
2
IR
63
-3
AMGN
42
-4
SIG
44
-3
O
17
-13
SHW
62
-6
XYL
35
-2
ROST
57
-3
OXY
36
-2
CAH
48
-6
AIV
64
4
CSX
57
-4
GRMN
67
-4
FOXA
52
-14
GILD
47
-8
ORLY
60
-5
WEC
53
5
TJX
62
-2
GME
66
-5
IFF
47
-4
CFG
74
2
IR
63
-3
Financhill
Back

Autolus Therapeutics PLC Vs. Halozyme Therapeutics Industry Stock Comparison

Sell
50

AUTL
Autolus Therapeutics PLC

Last Price:
3.08
Seasonality Move:
0.84%
Sell
39

HALO
Halozyme Therapeutics

Last Price:
45.65
Seasonality Move:
17.03%
Sell
50
Autolus Therapeutics PLC (AUTL) is a Sell

Is Autolus Therapeutics PLC a Buy, Sell or Hold?

  • The current Autolus Therapeutics PLC [AUTL] share price is $3.08. The Score for AUTL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • AUTL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
Halozyme Therapeutics (HALO) is a Sell

Is Halozyme Therapeutics a Buy, Sell or Hold?

  • The current Halozyme Therapeutics [HALO] share price is $45.65. The Score for HALO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
  • HALO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AUTL Stock Price Chart

What is Autolus Therapeutics PLC's stock price today?

  • The Autolus Therapeutics PLC share price today is $3.08
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUTL is experiencing slight buying pressure.

HALO Stock Price Chart

What is Halozyme Therapeutics's stock price today?

  • The Halozyme Therapeutics share price today is $45.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and HALO is experiencing selling pressure, which indicates risk of future bearish movement.

AUTL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.24 Sell
Relative Strength Index (14 RSI): 35.72 Sell
Chaikin Money Flow: 450973 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.4 - 4.46) Sell
Bollinger Bands (100): (3.55 - 4.35) Sell

HALO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.02 Sell
Relative Strength Index (14 RSI): 30.2 Sell
Chaikin Money Flow: -7140517 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (49.94 - 58.56) Sell
Bollinger Bands (100): (52.16 - 60.38) Sell

AUTL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.45 Sell
20-day SMA: 3.82 Sell
50-day SMA: 3.89 Sell
200-day SMA: 4.52 Sell
8-day EMA: 3.35 Sell
20-day EMA: 3.64 Sell
50-day EMA: 3.85 Sell
200-day EMA: 4.13 Sell

HALO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.53 Sell
20-day SMA: 54.48 Sell
50-day SMA: 56.18 Sell
200-day SMA: 48.93 Sell
8-day EMA: 55 Sell
20-day EMA: 55.41 Sell
50-day EMA: 55.64 Sell
200-day EMA: 50.73 Sell

Autolus Therapeutics PLC Earnings Growth & AUTL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.13 per share.

Halozyme Therapeutics Earnings Growth & HALO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.30 per share, and an increase next year of $0.71 per share.

Autolus Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Halozyme Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):